Therapeutic apheresis in neurological disorders: a survey of the evidence in support of current category I and II indications for therapeutic plasma exchange.
Neurologic disorders constitute the largest group of indications for therapeutic plasma exchange. Although some of the traditional indications are supported by properly designed randomized trials, others are not. This article provides a critical look at the evidence in support of the assignment by ASFA of Category I or II indications to neurologic disorders in its most recent (2007) evaluation of therapeutic apheresis.
Weinstein
Robert
R
Department of Medicine and Pathology, University of Massachusetts Medical School, Division of Transfusion Medicine, UMass Memorial Medical Center, Worcester, Massachusetts, USA. robert.weinstein@umassmemorial.org
D001781:Blood Component Removal; D006801:Humans; D009422:Nervous System Diseases / Q000628:therapy*; D010951:Plasma Exchange; D017410:Practice Guidelines as Topic